KEVZARA (sarilumab)

**Product type:** Human Prescription Drug

**Active ingredient:** SARILUMAB

**Strength:** 200 mg/1.14mL

**Dosage form:** Injection, Solution

**Route:** Subcutaneous

**Labeler:** Sanofi-Aventis U.S. LLC

**Marketing category:** BLA (BLA761037)

**Pharmacologic class:** Interleukin 6 Receptor Antagonists [MoA], Interleukin-6 Receptor Antagonist [EPC]